Sanjay D. Goorachurn Takes The Helm As Medisca CEO
KUALA LUMPUR, April 17 (Bernama) -- Medisca, a global company specialising in personalised pharmaceutical solutions sets a new chapter with the appointment of Sanjay D. Goorachurn as its new Chief Executive Officer (CEO).
Founders Tony Dos Santos and Maria Zaccardo, are transitioned into strategic advisory roles as Chair and Vice Chair, respectively, according to Medisca in a statement.
“Over the course of 35 years, Medisca has seen remarkable development, grounded in its people and dynamic entrepreneurial culture. With the addition of Sanjay’s unique set of experiences and skillset, we are confident that this marks the beginning of a new chapter for Medisca,” said Dos Santos.
Meanwhile, Goorachurn said: “My goal is to preserve the entrepreneurial legacy of Tony and Maria and carry forward the company’s vision to empower personalised wellness for all.
“My focus will be centred around empowering Medisca’s people, creating a more structured infrastructure for strategic growth, building key partnerships, and continuing to leverage innovative excellence that sets Medisca apart, while expanding our global presence.”
As a seasoned intellectual property (IP) lawyer with over 30 years of experience, Goorachurn is regarded as one of the world’s leading IP strategists working closely with senior executives of private and public companies on maximising the commercial value of a company’s innovation and IP assets.
It is Goorachurn’s distinct expertise and first-hand experience in implementing transformative growth for complex and global companies that drew Dos Santos and Zaccardo to him back in 2016, when he joined the Medisca team as a strategic advisor.
Coinciding with the company’s 35th anniversary, this decision marks a significant milestone in Medisca’s history which opened its doors as a team of three with two products and a vision to bridge the gaps in patient care in 1989.
Currently, Medisca is a global leader in personalised medicine with more than 10 locations spanning five countries, offering a vast portfolio of 2,000 plus product solutions to meet the needs of diverse healthcare sectors with a workforce of over 450 employees.
-- BERNAMA
Comments